By contrast, the high-expressed mRNA level of TLE3 was connected with poor PFS (progress-free survival) of ovarian cancer, poor OS, FP, and PPS of gastric cancer, and poor RFS, PFS, and DSS of liver cancer. The gene discussed is TLE3; the disease is liver cancer.